Speech Activities by Age

How to write a letter of medical necessity for AAC

A step-by-step guide to writing a letter of medical necessity for AAC devices. Covers what insurers require, who signs it, and how to avoid the top denial reasons.

Child and speech therapist reviewing an AAC communication device together at a table
Child and speech therapist reviewing an AAC communication device together at a table

Last updated 2026-07-11

A letter of medical necessity for AAC is a clinical document, almost always written by a speech-language pathologist, laying out why a child needs an augmentative and alternative communication device and genuinely can't manage without one. Most insurers won't approve coverage without it. Writing one well takes real time, usually 2 to 4 hours, and it needs to cover the diagnosis, the specific communication deficits, any device trials that were run, and research-backed reasoning for why this particular device is the right fit.

Think of the letter as the clinical argument standing between your child and an insurer agreeing to pay. It has to tell the company, in language they recognize, why this device is medically necessary rather than a nice-to-have.

Without a strong letter, claims get denied. AAC devices range from a few hundred dollars for simple hardware to over $10,000 for high-tech speech-generating devices, according to the American Speech-Language-Hearing Association, so there's real money on the line [1]. Insurers, Medicaid included, work under the framework set by the Assistive Technology Act of 1998 (29 U.S.C. § 3001 et seq.) and need the letter to justify coverage as a medical need rather than a consumer purchase [2].

This isn't a vague note about need. It's a structured clinical document, and the line between approval and denial usually comes down to whether the writer knew exactly what that insurer looks for. Most denials trace back to one of three gaps: missing functional data, no record of device trials, or a diagnosis that's listed but never tied to an actual communication deficit. Write it like a legal brief that answers the reviewer's objections before they get the chance to raise them.

Who should write it

The letter has to come from a licensed speech-language pathologist, no exceptions. Some insurers also want a physician's co-signature on the SLP's evaluation, but the clinical substance has to come from the SLP who actually ran the AAC assessment [3].

A pediatrician writing the letter alone almost always gets rejected, since physicians typically don't have the training to do AAC feature-matching. Their role is to document the underlying diagnosis and confirm medical necessity from a medical standpoint, not to recommend a specific device.

Here's roughly how the responsibilities split across the team:

RoleResponsibility in the LMN process
SLPAssessment, device trials, feature-matching, core of the letter
Physician / PediatricianCo-signature, medical diagnosis documentation
Parent / CaregiverProvides functional communication history, signs any consent forms
AAC Specialist or AT SpecialistMay assist with device trials if SLP has limited AAC experience

If your child's SLP hasn't written an AAC letter before, that's not a dealbreaker. Point them toward ASHA's guidance on AAC funding documentation, which walks through what's required [1]. Several AAC device manufacturers also run funding support teams that will review a draft letter for free, and that extra set of eyes tends to catch gaps before submission. Families going through an early intervention program sometimes get help with the referral through that team, but once a child ages out of Part C services (usually around age 3), the family has to navigate private insurance, Medicaid, or school-based funding on its own.

What actually needs to be in it

No single template covers every insurer, but the pieces below show up in nearly every funding policy. Leave one out and you're looking at a denial, or at best a request for more information that stalls things for weeks.

Start with patient demographics and diagnosis: full legal name, date of birth, insurance ID, and the specific ICD-10 code explaining the communication impairment. A child with autism typically gets F84.0; childhood apraxia of speech is coded R47.01 or F80.0 depending on severity and context [4]. The code alone proves nothing, though. The letter has to connect that diagnosis to an actual functional communication deficit.

Next comes current communication status, and this is where most letters fall apart. The SLP needs specifics, backed by standardized scores from tools like the Clinical Evaluation of Language Fundamentals (CELF-5), the Preschool Language Scales (PLS-5), or the Communication Matrix [5]. Writing "the patient has limited verbal output" accomplishes nothing. Writing "the patient scored at the 1st percentile for expressive language on the PLS-5 administered on [date] and produces fewer than 10 consistent functional words" is what actually moves a claim forward.

Then explain why cheaper options didn't work. Did the child try PECS and plateau? Did a low-tech communication board fail because motor planning needs outstripped what static symbols could support? This is where a diagnosis of apraxia of speech or childhood apraxia of speech matters, since the motor-speech piece gives a clean medical reason a speech-generating device is necessary rather than convenient.

Device trial documentation comes next: most insurers want proof that the recommended device was actually trialed and came out ahead. Name the specific device, model, and software, note the dates and length of the trial, describe the settings it happened in, and record what the clinician observed. Trialing two or three devices with comparison notes builds a stronger case than trialing just one.

From there, walk through the feature-matching rationale: why this device, with this vocabulary set and this access method, fits the child's motor, cognitive, visual, and linguistic profile. Note the access needs (direct selection, eye gaze, switch scanning) and explain how the recommended device meets them.

Add a prognosis and functional benefit statement spelling out what gains are expected. Citing peer-reviewed research relevant to the child's profile strengthens this part considerably. A 2006 study in the American Journal of Speech-Language Pathology found no evidence that AAC impedes speech development in people with developmental disabilities, and it may actually support it [6], which answers a common insurer objection directly.

Close with a physician attestation: a co-signature from the prescribing physician confirming medical necessity. Some insurers want this as a separate physician letter; others are fine with a co-signature on the SLP's letter.

How long it should be

Completeness matters more than length. A tight, well-organized four-page letter beats a sprawling eight-page one every time. Most solid letters run three to five single-spaced pages, with supporting material attached as exhibits rather than folded into the text.

Use plain numbered or lettered headers, and mirror the insurer's own criteria language whenever you can find it. Many Medicaid programs post their AAC coverage policies online, and matching their structure makes life easier for whoever reviews the file.

Attach these separately rather than burying them in the letter itself:

Keep the opening paragraph short and direct: name, age, diagnosis, and the exact device being requested, ideally all in the first sentence. Reviewers get through dozens of these letters. Bury the actual request on page two and you've made their job harder, which never helps your child.

Speaking the insurer's language

Insurers, especially Medicare and Medicaid, say "speech-generating device" (SGD), not AAC. Medicare covers SGDs as Durable Medical Equipment under the Medicare Benefit Policy Manual, Chapter 15 [7], and if you're writing for a Medicare or Medicare Advantage beneficiary, using that exact term matters because coverage criteria are built around it.

Medicare requires the patient to have a severe expressive speech impairment from a chronic medical condition, to be able to benefit from a device at home, and to be unable to communicate functionally with natural speech alone. Address those three points directly, almost like a checklist.

Medicaid coverage varies by state, but most state programs cover AAC under the Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit for children under 21, which requires states to cover any medically necessary service regardless of whether it's covered for adults [8]. That's worth knowing, because if a state Medicaid plan denies a device for a child under 21, EPSDT becomes the basis for an appeal.

For private insurance, get the plan's prior authorization criteria from the provider relations line before writing anything, and align the letter to it. Some plans follow Medicare's SGD criteria closely; others use their own language around "functional communication" or "least restrictive alternative."

One line worth quoting directly: the American Academy of Pediatrics states that "communication is a basic human right" and recommends clinicians advocate for AAC access as part of a child's medical care [9]. Citing AAP policy by name in a letter to a private insurer tends to carry real weight.

What are the most common reasons AAC letters get denied?

A denial isn't the end of the road, and honestly, it's the norm. Most AAC requests get approved only after at least one denial and an appeal. Knowing why letters get rejected in the first place helps you write a stronger one from the start.

The most common reason cited is "not medically necessary." That usually means the letter didn't tie the diagnosis to the functional deficit clearly enough, or described the deficit without standardized data behind it. The fix is to add assessment scores and name the specific daily activities the patient can't do without AAC.

"Device not the least costly alternative" means the insurer believes a cheaper option would work just as well. Your feature-matching section needs to explain plainly why lower-cost devices were tried and why they fell short for this particular patient.

"No documented device trial" is a paperwork problem more than anything else. If the SLP can't produce dated trial notes, there's no foundation for the claim. The documentation doesn't need to be elaborate, but it does need to exist and be attached.

"Diagnosis does not support coverage" tends to show up when a code is submitted with no narrative around it. A child with autism whose letter only lists "F84.0" without explaining the communication impairment tied to that diagnosis will run into this wall.

Expired or missing signatures cause denials too, of the administrative kind. Some insurers require physician signatures dated within 30 or 60 days of submission, so it's worth double-checking dates before anything gets mailed.

If a letter does get denied, request the denial in writing along with the specific criteria that weren't met. That document becomes your roadmap for the appeal.

How does the appeals process work if the letter is denied?

Under the Affordable Care Act, all non-grandfathered private health plans have to offer an internal appeals process and access to external review [10]. So a first-round denial is never really the final word.

For internal appeals, you typically have 180 days from the denial to file. A strong appeal includes a revised or expanded LMN that answers each denial reason point by point, a letter from the prescribing physician that argues medical necessity rather than just co-signing, citations to peer-reviewed research, and a statement from the family describing the functional impact on daily life.

External review brings in an independent reviewer with no ties to the insurer. Reviewers who specialize in assistive technology tend to rule in the patient's favor more often than internal reviewers do, though solid national data on AAC-specific external review outcomes is hard to come by.

Medicaid appeals work differently. Families can request a fair hearing, and for children under 21 the EPSDT mandate is once again the central argument [8]. State-level disability rights organizations often offer free legal help for Medicaid fair hearings involving AAC, and the Assistive Technology Act programs in each state (funded under 29 U.S.C. § 3001) can provide advocacy support as well [2].

Don't wait to start the appeal. The clock starts on the denial date, and delays in getting a child an AAC device carry real consequences for language development.

Does Medicaid cover AAC devices for children, and does the letter need to say anything different?

Yes, Medicaid covers AAC devices for children, and the EPSDT mandate actually makes the coverage argument stronger for kids than it is for adults. Under EPSDT, state Medicaid programs must cover any service that is "medically necessary" to correct or ameliorate a physical or mental condition in a child under 21, whether or not that service is listed in the state plan [8].

The word "ameliorate" is doing a lot of work in that sentence. It's an intentionally broad standard: a service doesn't have to cure a condition, just improve or compensate for it. An AAC device clearly clears that bar for a child with a severe expressive communication disorder.

For a Medicaid LMN, name EPSDT directly and cite the federal requirement. Note the child's age and confirm the request falls within the EPSDT benefit period. Some SLPs skip this step and write the same letter they'd send a private insurer, leaving the strongest argument on the table.

State Medicaid programs also differ on whether they require a separate evaluation by a certified assistive technology professional (ATP). It's worth checking your state's Medicaid provider manual before submitting anything. Roughly 20 states require the ATP credential on evaluations for high-cost devices, though that number shifts as states update their policies.

What does a sample LMN outline look like?

This isn't meant as a fill-in-the-blank template. A template without real assessment data behind it reads like a form letter and tends to get flagged. Think of this instead as a structure to build from.

---

[SLP's letterhead, license number, date]

RE: Medical Necessity for Speech-Generating Device Patient: [Full name, DOB, Insurance ID] Requesting Provider: [SLP name, credentials, NPI] Prescribing Physician: [Name, NPI, specialty]

Section 1: Introduction and Request State the specific device requested (manufacturer, model, software/vocabulary system) and the diagnosis codes.

Section 2: Diagnosis and Medical History Explain the diagnosed condition(s) and how they produce a severe expressive communication disorder. Reference the physician's records. Include relevant co-occurring conditions (motor impairment, cognitive profile, sensory needs).

Section 3: Current Communication Status Standardized assessment data. List every test administered, date, and relevant subtest scores. Describe functional communication: what the patient cannot do in daily life, at school, with family, in medical settings.

Section 4: Prior and Current Interventions Document the history of speech therapy the child has received. What was tried, what were the outcomes, and why hasn't natural speech progressed to functional communication?

Section 5: Device Trials For each device trialed: name, dates, access method used, vocabulary system, observed patient performance, and why this device was or was not selected. The recommended device should show the strongest functional gains.

Section 6: Feature Matching and Justification for Requested Device Connect patient needs to device features one by one. Access method, vocabulary depth, language representation, portability, durability, and customizability.

Section 7: Functional Benefit and Prognosis Anticipated gains. Timeline for reassessment. Cite relevant research.

Section 8: Summary and Request Restate the request clearly. Include the device cost if the insurer requires it.

Signatures: SLP (with date and license number), Physician (with date and NPI)

---

One practical note: the SLP should keep a copy of everything submitted and log the date and method of submission (mail, fax, portal) in the patient file. That record matters if the insurer later claims they never received it.

How can parents support the SLP in writing a stronger letter?

Parents are often the best source of functional communication data, and most SLPs genuinely want that input. A written communication diary kept for two to four weeks before the assessment is worth the effort. It can capture how many times a day the child communicated a want or need, how often those attempts were misunderstood, whether the child got frustrated or withdrew, and what strategies the family had already tried.

It also helps to pull together the child's school IEP if one exists. The present levels of performance (PLOP) section often contains language about communication deficits that the SLP can quote directly in the LMN, with the family's permission.

If your child has used low-tech supports, take photos. Visual evidence of a child working with a PECS board or a communication book, alongside the clear limits of that approach, is something some insurers accept as part of the documentation.

Families using supplemental tools like the Little Words app alongside therapy might find the SLP willing to reference that app-based practice as extra evidence of the child's communication attempts and patterns outside clinical sessions. Any real-world data on communication frequency and modality helps round out the picture.

It's also worth asking your SLP whether the device manufacturer has a funding support team. Companies like Tobii Dynavox, PRC-Saltillo, and Lingraphica employ staff whose entire job is helping families navigate the funding process. They won't write the letter for you, but they'll review it and catch problems before it goes out.

How long does the AAC funding process typically take?

Longer than it should, honestly. From the first evaluation to the device actually arriving, families commonly wait three to nine months. That range is wide because so much depends on the insurer, whether you end up appealing, and how quickly the paperwork comes together.

Here's a rough breakdown of the major steps:

StepTypical Timeframe
AAC evaluation by SLP1-3 sessions over 2-6 weeks
LMN written and signed1-3 weeks after evaluation
Prior authorization decision15-30 business days (varies by insurer)
Denial and internal appealAdd 30-60 days
External review (if needed)Add 45-60 days
Device order processing and delivery2-6 weeks after approval

Medicare Advantage plans generally have to decide on standard prior authorization requests within 14 days, and expedited ones within 72 hours [7]. Private insurers vary, but state law typically requires a decision within 30 to 45 calendar days for standard requests.

If you're past the six-month mark, you can ask the insurer for an expedited review on the grounds that the delay is causing harm, such as missed developmental windows for language acquisition. Putting that harm in writing, backed by the SLP's clinical opinion, makes the request stronger.

For families working through autism spectrum speech therapy, ages 2 through 5 are when language acquisition responds best to intervention, which is exactly why delays in AAC access cost so much in developmental terms [11].

Typical AAC funding timeline by stage Approximate weeks from evaluation start to device delivery (no appeals assumed) AAC evaluation (1-3 sessions) 4 weeks LMN written and signed 2 weeks Prior authorization decision 5 weeks Device order and delivery 4 weeks Source: CMS Medicare Benefit Policy Manual (Ch. 15) and ASHA AAC Funding Guidance, combined with common clinical practice ranges

Are there free resources or templates to help write the letter?

There are, and knowing where to look saves a lot of time. ASHA maintains a funding resources page with state-by-state Medicaid coverage information and documentation guidelines [1]. Every state also has an assistive technology program funded under the Assistive Technology Act; these run device lending libraries worth using for trials, offer funding assistance, and sometimes help directly with LMN documentation. You can find your state's program through the AT3 Center [2].

Device manufacturers like Tobii Dynavox, PRC-Saltillo, and Lingraphica all offer funding navigation support. They're motivated to help because it drives sales, but the help itself is real. State Protection and Advocacy agencies provide free legal help for AAC funding appeals, and the National Disability Rights Network can point you to your state's P&A office. Federally funded research centers focused on AAC have also published guidance on funding and documentation, and that material is publicly available through federal archives.

One warning about generic templates found through a web search: if a letter isn't tailored to the insurer's criteria and the patient's actual assessment data, it's worse than useless. It signals to the reviewer that the letter wasn't written for this child, and some reviewers deny on that basis alone.

Frequently asked questions

Can a parent write the letter themselves?

No. It has to come from a licensed speech-language pathologist, and most insurers also want a physician's signature on it. A parent can submit their own statement alongside the clinical letter to describe how the lack of communication plays out at home, and that kind of supplement genuinely helps, but it can't stand in for the SLP's documentation. If your child doesn't have an SLP yet, ask your pediatrician for a referral or contact your state's early intervention program.

What ICD-10 codes show up in these letters?

Common ones include F84.0 (autism spectrum disorder), F80.1 (expressive language disorder), F80.0 (phonological disorder), R47.01 (aphasia), and F80.82 (childhood onset fluency disorder). Which one applies depends on the diagnosis, and the SLP and prescribing physician need to agree on it before anything gets submitted. A mismatch between the physician's diagnosis and the SLP's chosen code is one of the most common reasons these requests get denied on administrative grounds.

Does Medicare cover AAC devices?

Medicare covers speech-generating devices as durable medical equipment under Part B, but three things have to be true: the patient has a severe expressive speech impairment from a chronic medical condition, they can benefit from the device at home, and they can't communicate functionally through natural speech alone. The letter needs to use the actual term "speech-generating device" and address all three points directly. The Medicare Benefit Policy Manual, Chapter 15, lays out the coverage criteria.

What if the insurer calls AAC "educational" instead of "medical"?

This is a common denial tactic, and the letter should get ahead of it by documenting that the child needs AAC everywhere, not just at school: at home, at medical appointments, out in the community. Medical necessity comes from the diagnosis and the functional communication deficit, not from where the device happens to get used. If a denial still comes back on educational grounds, the EPSDT mandate requires Medicaid to cover medically necessary services for enrolled children under 21 regardless of that framing.

How often does the letter need renewing?

Most insurers want re-authorization every one to three years, or whenever a device upgrade is needed. The renewal letter follows the same basic format as the first one, but it should describe the progress made with the current device, note any changes in how the child communicates, and explain why an upgrade or replacement is now necessary. Hang on to the original letter and approval, since they're useful evidence when it's time to renew.

Can Medicaid and private insurance both cover the same device?

Yes, through coordination of benefits. Medicaid usually acts as the payer of last resort, so private insurance gets billed first, and if it covers part of the cost but not all of it, Medicaid can pick up the remaining balance for enrolled children. Both payers will want their own copy of the letter. Tell both insurers about the dual coverage from the start so you don't end up stuck in a coordination dispute that delays the device.

What if the school says they'll provide AAC through the IEP?

A school-provided device is tied to educational goals and stays at school. It can't legally or ethically replace a medically necessary device your child needs at home, at appointments, and in the community, since the IEP and the medical letter serve different purposes and come from different funding streams. Families can pursue both at once. The school placement should show up in the letter as evidence of communication need, not as proof that the need is already covered.

Does the cost of the device affect the letter?

High-tech speech-generating devices generally run $3,000 to $12,000 depending on the hardware, mounting system, and software, while simpler dedicated devices with limited vocabulary might cost $150 to $1,500. The letter should mention cost if the insurer needs it for prior authorization, but cost doesn't change the medical necessity argument itself, which is always about functional need rather than price. What justifies a pricier device is how well it matches the patient's specific communication profile.

How is the AAC evaluation different from the letter?

The evaluation is the clinical process, the part where the SLP assesses the child, trials different devices, matches features to needs, and writes up a report. It usually takes two to four sessions. The letter of medical necessity is shorter and more targeted: it pulls the evaluation's findings into the language the insurer needs to make a coverage decision. Both get submitted together, with the evaluation report as the exhibit and the letter as the argument.

Can a telehealth SLP write one of these letters?

Yes, as long as they're licensed in the state where the patient lives and can carry out a thorough evaluation. Some insurers insist on in-person device trials, which can complicate a fully remote process, so the SLP may need to coordinate with a local AAC lending library or a device manufacturer's rep to arrange hands-on trials. If you're working with an online speech therapist, ask directly whether they've handled AAC evaluations and funding paperwork before you get started.

What research helps strengthen the letter?

The study cited most often is Millar, Light, and Schlosser (2006) in the American Journal of Speech-Language Pathology, which found no evidence that AAC gets in the way of speech development. Romski and Sevcik's work on AAC and language learning in children with developmental disabilities also comes up frequently, and for autism specifically, there's research on AAC outcomes in that population worth pulling in. The SLP should pick studies that fit the child's actual diagnosis rather than leaning on generic AAC research.

What if the SLP has never written one of these before?

Have them consult an AAC specialist or reach out to the device manufacturer's funding support team before writing anything. ASHA's Special Interest Group 12 (AAC) has resources and a network of SLPs with funding experience. That alone isn't a reason to switch clinicians if the relationship is otherwise a good one: writing a letter like this is a learnable skill, and plenty of strong clinicians just haven't run into it yet. What matters is whether they're willing to do it carefully.

Is the letter different for a child versus an adult?

The structure stays the same, but the justification changes quite a bit. EPSDT doesn't apply to adults, so an adult's letter has to stand on its own under the insurer's regular adult coverage criteria. Adults are also more likely to need AAC because of an acquired condition like ALS, stroke-related aphasia, or traumatic brain injury, and the letter should tie the device directly to that impairment. Medicare's criteria for speech-generating devices apply the same way to adults and children, but Medicaid's strongest protections belong specifically to patients under 21.

Sources

  1. American Speech-Language-Hearing Association (ASHA), AAC Funding and Advocacy: ASHA estimates AAC devices range from a few hundred to over $10,000; ASHA publishes documentation guidance for AAC funding.
  2. Assistive Technology Act of 1998, 29 U.S.C. § 3001, AT3 Center (State AT Programs): The Assistive Technology Act funds state AT programs that offer device lending, funding assistance, and advocacy support.
  3. ASHA, Scope of Practice in Speech-Language Pathology: AAC evaluation and device recommendation fall within the SLP's scope of practice; physician co-signature documents the medical diagnosis.
  4. Centers for Disease Control and Prevention, ICD-10-CM Diagnosis Codes: ICD-10 codes such as F84.0 (autism spectrum disorder) and F80.1 (expressive language disorder) are used to document diagnoses in AAC LMNs.
  5. Communication Matrix, research-based communication assessment tool: The Communication Matrix is a standardized tool used by SLPs to document functional communication levels in AAC assessments.
  6. Millar, D.C., Light, J.C., & Schlosser, R.W. (2006). The impact of augmentative and alternative communication intervention on speech production in individuals with developmental disabilities. American Journal of Speech-Language Pathology, 15(3), 228-237.: AAC does not impede speech development in children with developmental disabilities and may support it, per this 2006 study in the American Journal of Speech-Language Pathology.
  7. Medicaid.gov, Early and Periodic Screening, Diagnostic and Treatment (EPSDT): Under EPSDT, state Medicaid programs must cover all medically necessary services for children under 21, including AAC devices, regardless of whether those services are listed in the state plan.
  8. American Academy of Pediatrics (AAP), policy on communication access: The AAP states that communication is a basic human right and recommends clinicians advocate for AAC access as part of a child's medical care.
  9. HealthCare.gov, Your rights to appeal a health insurance company decision: Under the Affordable Care Act, all non-grandfathered private health plans must offer an internal appeals process and access to external review.
  10. National Institute on Deafness and Other Communication Disorders (NIDCD), Speech and Language Developmental Milestones: The window between ages 2 and 5 is most responsive to language intervention, making timely AAC access developmentally significant.
  11. Assistive Technology Act of 1998, 29 U.S.C. § 3001 et seq.: The Assistive Technology Act of 1998 establishes the legal framework under which state AT programs and Medicaid AT coverage are structured.
AAC and talking practice work best side by side.

Little Words is a voice-first app where your child talks and plays with Buddy at home, low-pressure practice that sits alongside their device. It is free to download.

See your child's planor download on the App Store